Abstract:Abstract Cancer stem cells (CSCs) have been identified in primary breast cancer tissues and cell lines. The size of CSC population varies a lot among cancer tissues and cell lines but is associated with aggressiveness of breast cancer. Despite of the high tumor heterogeneity among different samples, CSCs isolated from either primary tissues or cell lines can rapidly regenerate the original heterogeneity and maintain a relatively constant proportion of CSCs. It remains largely unknown how the CSC population is maintained within a tumor. In this study, we develop a mathematical model to explore the key factors which control the size of CSC population during tumor cell growth both in vitro and in vivo. Our mathematic modeling and experimental data suggest that there is a negative feedback mechanism to control the balance between CSC and non-stem cancer cells. We further calculated how feedback sensitivities and robustness can be regulated by different intrinsic and extrinsic factors. As an example, our mathematical model predicts that overexpression of oncogeneHER2 leads to increase in the proportion of CSC via regulating the division mode or proliferation rate of CSCs. The prediction is supported by both in vitro cell culture results and the clinical data. We also show that enrichment of CSCs in suspension culture is due to both depletion of differentiated cancer cells and partial relieve of negative feedback. Mathematical modeling this culture condition reveals that the majority of tumporspheres are derived from progenitor cancer cells but not CSCs. Overall, these findings contribute to our understanding of cancer heterogeneity and may have significant implications in development and selection of anti-cancer therapies. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-203. doi:1538-7445.AM2012-LB-203

Replicator Dynamics of of Cancer Stem Cell; Selection in the Presence of Differentiation and Plasticity

Cancer Stem Cell, Niche and EGFR Decide Tumor Development and Treatment Response: A Bio-Computational Simulation Study.

Phenotypic heterogeneity in modeling cancer evolution

Effect of Dedifferentiation on Time to Mutation Acquisition in Stem Cell-Driven Cancers

Stochastic population dynamics of cancer stemness and adaptive response to therapies

A multi-phenotypic cancer model with cell plasticity

Modeling tumorspheres reveals cancer stem cell niche building and plasticity

Population Dynamics of Cancer Cells with Cell State Conversions

Dynamics Between Cancer Cell Subpopulations Reveals A Model Coordinating With Both Hierarchical And Stochastic Concepts

A SIMPLE EVOLUTIONARY MODEL FOR CANCER CELL POPULATION AND ITS IMPLICATIONS ON CANCER THERAPY

Mechanically-driven stem cell separation in tissues caused by proliferating daughter cells

The prisoner’s dilemma as a cancer model

Senescent Cells in Growing Tumors: Population Dynamics and Cancer Stem Cells

Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential Mechanism

Cancer stem cells: a shifting subpopulation of cells with stemness?

Abstract LB-203: Mathematical Modeling of the Dynamic Interaction Between Cancers Stem Cells and Non-Stem Cancer Cells and Its Potential Clinical Implication

Dynamic Regulation of Cancer Stem Cells and Clinical Challenges.

Growth of cancer stem cell driven tumors: staged invasion, linear determinacy, and the tumor invasion paradox

A physical mechanism of heterogeneity in stem cell, cancer and cancer stem cell

An evolutionary model of tumor cell kinetics and the emergence of molecular heterogeneity driving Gompertzian growth